中文

← All funding rounds

Perceptic

EuropeBiology data and toolsLondon (most of its engineering), United KingdomPrivate

Website · perceptic.ai ↗

Software that runs AI agents over a drug company's public, internal and purchased data, with every claim traced to its source, for asset scouting, indication choice and clinical trial design.

Disclosed total$12M
Rounds on record1
Latest round$12MSeed · 2026-05-26
Last stated valuationNone stated
Investors named3
Research on recordNone yet

Money and evidence

Moneyeach round in US dollars; ≈ converted at its date$12M
Closed round

No research by this company is on the record yet.

Rounds and research, on one timeline

  1. 2026-05-26Seed
    Round

    $12M

    For: engineering and growing its customer base

    Models and platformCommercial roll-out

    First reported by Fortune as an exclusive, with the chief executive, Accel's Sonali De Rycker and Air Street's Nathan Benaich on the record. Valuation not disclosed.

    Lead · AccelAir Street CapitalElder Gull

    On the deal: Nathan Benaich (Founder and General Partner; gave a statement, Air Street Capital); Sonali De Rycker (Partner; led the firm's investment, Accel)

    Announced by the company · fortune.com ↗On the timeline →

Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.

See these rounds in the table →

Its investors also backed

Other companies on this page whose rounds name the same investor.